Through the Institute of Molecular Biology of Paraná (IBMP), the Oswaldo Cruz Foundation (Fiocruz) delivered, on Wednesday (8), the first batch of supplies for testing monkeypox (monkeypox) in humans. Positive controls aid in the reliable diagnosis of viral disease and were produced within one week.
- Monkeypox kills? Disease is less serious than smallpox
- Brazil confirms 1st case of monkeypox
“We use raw materials and our expertise in the development of diagnostic kits, in addition to what has been published in the international scientific literature, to produce quality reactions that enable the accurate and safe molecular diagnosis of the Monkeypox virus”, explains the Development Manager. IBMP Technologist, Fabricio K. Marchini, in a statement about the initiative.
It is worth remembering that, on Wednesday (8), Brazil confirmed the first official case of monkeypox in the city of São Paulo. The patient would have returned from a recent trip to Spain. In addition to this case, another eight are under investigation, according to the Ministry of Health.
Where do Fiocruz’s inputs go?
The first batch of supplies for monkeypox testing was distributed on two fronts:
- Part of the production was delivered to the Pan American Health Organization (PAHO) — the regional office of the World Health Organization (WHO). In turn, they will be shipped to at least 20 countries;
- Another part was distributed to reference laboratories in Brazil, that is, institutions that have the capacity to diagnose cases of monkeypox in humans.
Who diagnoses monkeypox?
At the moment, the number of laboratories that are able to diagnose monkeypox is quite limited in Brazil. Below, check out the only 4 research centers suitable for the procedure:
- Laboratory of Molecular Biology of Viruses of the Carlos Chagas Filho Institute of Biophysics of the Federal University of Rio de Janeiro (LBMV/IBCCF/UFRJ), in Rio de Janeiro;
- Central Public Health Laboratory of Minas Gerais/Ezequiel Dias Foundation (Lacen/Funed), in Minas Gerais;
- Central Public Health Laboratory of São Paulo/Instituto Adolfo Lutz (Lacen/IAL), in São Paulo;
- Enterovirus Reference Laboratory at the Oswaldo Cruz Institute (IOC/Fiocruz), in Rio de Janeiro.
Measures such as Fiocruz’s should gradually increase testing centers for the disease in the country, as it facilitates access to test supplies. Initiative is important, because infected patients must remain in isolation, preventing the spread of the virus.